Skip to main content
Cancer Management and Research logoLink to Cancer Management and Research
. 2020 Aug 5;12:6861–6862. doi: 10.2147/CMAR.S273562

Glucosamine-6-Phosphate Isomerase 1 Promotes Tumor Progression and Indicates Poor Prognosis in Hepatocellular Carcinoma [Corrigendum]

PMCID: PMC7429113  PMID: 32848458

Li D, Cheng X, Zheng W, Chen J. Cancer Manag Res. 2020;12:4923–4935.

The authors have advised Figure 5E on page 4931 is incorrect. Due to an error at the time of figure assembly shGNPDA1-1 and shGNPDA1-2 in the SMMC-7721 column were duplicated. The correct Figure 5 is shown below.

Figure 5.

Figure 5

GNPDA1 enhances cell proliferation. (A) Results of the MTT assay performed in SMMC-7721 and Huh7 cells with GNPDA1 knockdown and controls. (B) Representative images of the cell cycle analysis. (C) GNPDA1 knockdown induced G0/G1 arrest. (D) Representative images of the EdU proliferation assay. (E) Quantification of EdU-positive cells (n = 3). *P < 0.05, **P < 0.01, and ***P < 0.001.

Abbreviations: shctrl, the control cell line of cell line with low GNPDA1; shGNPDA1-1, Cell line numbered 1 with low GNPDA1; shGNPDA1-2, Cell line numbered 2 with low GNPDA1; GNPDA1, glucosamine-6-phosphate isomerase 1.

The authors apologize for this error and advise it does not affect the results of the paper.


Articles from Cancer Management and Research are provided here courtesy of Dove Press

RESOURCES